145 related articles for article (PubMed ID: 17006909)
41. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection.
Kitson MT; George J; Dore GJ; Leung R; Button P; McCaughan GW; Grawford DH; Siebert W; Weltman MD; Cheng WS; Roberts SK
J Gastroenterol Hepatol; 2014; 29(7):1458-62. PubMed ID: 25587616
[TBL] [Abstract][Full Text] [Related]
42. Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1.
Howell CD; Gorden A; Ryan KA; Thompson AJ; Ibrahim C; Fried M; Afdhal NH; McHutchison JG; Shianna KV; Goldstein DB; Shuldiner AR; Mitchell BD
J Hepatol; 2012 Mar; 56(3):557-63. PubMed ID: 22027585
[TBL] [Abstract][Full Text] [Related]
43. Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.
Holmberg SD; Lu M; Rupp LB; Lamerato LE; Moorman AC; Vijayadeva V; Boscarino JA; Henkle EM; Gordon SC;
Clin Infect Dis; 2013 Jul; 57(2):240-6. PubMed ID: 23592832
[TBL] [Abstract][Full Text] [Related]
44. Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients.
Patel K; Thompson AJ; Chuang WL; Lee CM; Peng CY; Shanmuganathan G; Thongsawat S; Tanwandee T; Mahachai V; Pramoolsinsap C; Cho M; Han KH; Shah SR; Foster GR; Clark PJ; Pulkstenis E; Subramanian GM; McHutchison JG
J Gastroenterol Hepatol; 2011 Jul; 26(7):1182-8. PubMed ID: 21410752
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic performance of collagen IV and laminin for the prediction of fibrosis and cirrhosis in chronic hepatitis C patients: a multicenter study.
El-Mezayen HA; Habib S; Marzok HF; Saad MH
Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):378-85. PubMed ID: 25874509
[TBL] [Abstract][Full Text] [Related]
46. Treatment of chronic hepatitis C virus in the virginia department of corrections: can compliance overcome racial differences to response?
Sterling RK; Hofmann CM; Luketic VA; Sanyal AJ; Contos MJ; Mills AS; Shiffman ML
Am J Gastroenterol; 2004 May; 99(5):866-72. PubMed ID: 15128352
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of accuracy of elastography point quantification versus other noninvasive modalities in staging of fibrosis in chronic hepatitis C virus patients.
Fouad R; Elbaz T; Abdel Alem S; Elsharkawy A; Negm M; Khairy M; Hassany M; Cordie A; El Akel W; Esmat G
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):882-887. PubMed ID: 29727382
[TBL] [Abstract][Full Text] [Related]
48. Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4.
Saad Y; Ahmed A; Saleh DA; Doss W
Eur J Gastroenterol Hepatol; 2013 Aug; 25(8):920-5. PubMed ID: 23442415
[TBL] [Abstract][Full Text] [Related]
49. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
Al-Mohri H; Cooper C; Murphy T; Klein MB
HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
[TBL] [Abstract][Full Text] [Related]
50. The predictive value of noninvasive serum markers of liver fibrosis in patients with chronic hepatitis C.
Gökcan H; Kuzu UB; Öztaş E; Saygılı F; Öztuna D; Suna N; Tenlik İ; Akdoğan M; Kaçar S; Kılıç ZM; Kayaçetin E
Turk J Gastroenterol; 2016 Mar; 27(2):156-64. PubMed ID: 26853790
[TBL] [Abstract][Full Text] [Related]
51. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.
Sterling RK; Lissen E; Clumeck N; Sola R; Correa MC; Montaner J; S Sulkowski M; Torriani FJ; Dieterich DT; Thomas DL; Messinger D; Nelson M;
Hepatology; 2006 Jun; 43(6):1317-25. PubMed ID: 16729309
[TBL] [Abstract][Full Text] [Related]
52. Role of IL-28B genetic variants in HCV-related liver disease severity in patients with different viral genotypes.
Huang CI; Huang CF; Yeh ML; Lin YH; Liang PC; Liu SV; Hsieh MH; Lin ZY; Chen SC; Huang JF; Chuang WL; Dai CY; Yu ML
Medicine (Baltimore); 2018 Mar; 97(10):e9782. PubMed ID: 29517696
[TBL] [Abstract][Full Text] [Related]
53. A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.
Méndez-Navarro J; Chirino RA; Corey KE; Gorospe EC; Zheng H; Morán S; Juarez JA; Chung RT; Dehesa-Violante M
Dig Dis Sci; 2010 Sep; 55(9):2629-35. PubMed ID: 19960257
[TBL] [Abstract][Full Text] [Related]
54. Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.
Lin ZH; Xin YN; Dong QJ; Wang Q; Jiang XJ; Zhan SH; Sun Y; Xuan SY
Hepatology; 2011 Mar; 53(3):726-36. PubMed ID: 21319189
[TBL] [Abstract][Full Text] [Related]
55. Non-invasive fibrosis assessment predicts sustained virological response to telaprevir with pegylated interferon and ribavirin for chronic hepatitis C.
Ogawa E; Furusyo N; Shimizu M; Ihara T; Hayashi T; Harada Y; Toyoda K; Murata M; Hayashi J
Antivir Ther; 2015; 20(2):185-92. PubMed ID: 24941012
[TBL] [Abstract][Full Text] [Related]
56. Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.
Jin R; Cai L; Tan M; McHutchison JG; Dowling TC; Howell CD
Am J Gastroenterol; 2012 Nov; 107(11):1675-83. PubMed ID: 23090351
[TBL] [Abstract][Full Text] [Related]
57. Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.
El Raziky M; Attia D; El Akel W; Shaker O; Khatab H; Abdo S; Elsharkawy A; Esmat G
Arab J Gastroenterol; 2013 Sep; 14(3):94-8. PubMed ID: 24206736
[TBL] [Abstract][Full Text] [Related]
58. Association of IL28B genotype with fibrosis progression and clinical outcomes in patients with chronic hepatitis C: a longitudinal analysis.
Noureddin M; Wright EC; Alter HJ; Clark S; Thomas E; Chen R; Zhao X; Conry-Cantilena C; Kleiner DE; Liang TJ; Ghany MG
Hepatology; 2013 Nov; 58(5):1548-57. PubMed ID: 23703931
[TBL] [Abstract][Full Text] [Related]
59. King's Score: an accurate marker of cirrhosis in chronic hepatitis C.
Cross TJ; Rizzi P; Berry PA; Bruce M; Portmann B; Harrison PM
Eur J Gastroenterol Hepatol; 2009 Jul; 21(7):730-8. PubMed ID: 19430302
[TBL] [Abstract][Full Text] [Related]
60. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
